Isoniazide hepatic damage as opposed to prophylactic treatment for tuberculosis
Oliven, A.; Odeh, M.; Bassan, H.
Harefuah 122(4): 254-257
1992
ISSN/ISBN: 0017-7768 PMID: 1563691 Document Number: 403131
Document emailed within 1 workday
Related Documents
Albengres, E.; Houin, G.; Breau, J.L.; Hirsch, A.; Saltiel, J.C.; Tillement, J.P.; Chrétien, J. 1977: Modification during treatment of the rate of acetylation of isoniazide clinically or biologically detectable hepatic damage La Nouvelle Presse Medicale 6(32): 2869-2871Dina, M.A.; Logroscino, G.S.; Caprino, L.; Togna, G. 1975: Ultrastructural study of the activity of phospholipids in experimental liver damage induced by isoniazide Il Farmaco; Edizione Scientifica 30(12): 955-964
Blanco Ramos, J.R.; Rosel Rioja, L.; Dopereiro Gómez, R.; Oteo Revuelta, J.A. 1997: Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide Anales de Medicina Interna 14(8): 433-434
Steensma, J.T. 1988: The sense of prophylactic treatment of tuberculosis Nederlands Tijdschrift Voor Geneeskunde 132(2): 65-67
Roosendaal, G.; Lafeber, F.P.J.G. 2007: Prophylactic treatment with clotting factor to prevent joint damage in patients with severe haemophilia: costs versus benefits Nederlands Tijdschrift Voor Geneeskunde 151(47): 2606-2608
Ishida, H.; Takeuchi, I.; Ohsawa, T.; Nakada, H.; Ishizuka, N.; Yokoyama, M.; Inokuma, S.; Suzuki, T.; Yamada, H.; Odaka, A.; Hoshino, T.; Murata, N.; Hashimoto, D.; Matsumoto, Y.; Miura, T. 2002: Hepatic recurrence after prophylactic hepatic arterial infusion of 5-fluorouracil for Dukes' C colorectal cancer--correlation with the expression of dihydropyrimidine dehydrogenase in the primary tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(12): 2267-2270
Wernsdorfer, G.; Wernsdorfer, W.H. 1970: Antituberculosis treatment with pasiniazide (isoniazide p-aminosalicylate): experimental and clinical aspects Maroc Medical 50(533): 164-168
Tschan, M.; Neuhaus, K. 1978: Bone-marrow damage by medicaments: diagnostic, therapeutic and prophylactic measurements Schweizerische Rundschau für Medizin Praxis 67(31): 1124-1128
Peura, D.A.; Koretz, R.L. 1990: Controversies, dilemmas, and dialogues. Prophylactic therapy of stress-related mucosal damage: why, which, who, and so what? American Journal of Gastroenterology 85(8): 935-937
Schapira, D.; Nahir, A.M. 1986: Chrysotherapy induced hepatic damage Harefuah 110(1): 14-15
Furs, L.N. 1980: Experience in organizing and conducting prophylactic examinations for tuberculosis in an urban population Problemy Tuberkuleza 1: 23-26
Masobe, P.; Lee, T.; Price, M. 1995: Isoniazid prophylactic therapy for tuberculosis in HIV-seropositive patients--a least-cost analysis South African Medical Journal 85(2): 75-81
Tabidze, S.A.; Rukhadze, L.P.; Berdzenishvili, M.K. 1981: Diagnostic and prophylactic work of the tuberculosis control dispensary among children and adolescents Problemy Tuberkuleza 1: 10-12
Konopka, K.; Mlodyszewska, M. 1976: Case of drug-induced hepatic damage Polski Tygodnik Lekarski 31(36): 1591-1592
Weigel, B. 1976: Changes of the tuberculosis of the central nervous system since the introduction of prophylactic BCG vaccination and tuberculostatic therapy Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 120(1): 21-33
Parra Ruiz, J.; Ortego Centeno, N.; Raya Alvarez, E. 2003: Development of tuberculosis in a patient treated with infliximab who had received prophylactic therapy with isoniazid Journal of Rheumatology 30(7): 1657-1658
Ubaĭdullaev, A.M.; Ginzburg, V.S.; Khamrakulov, R.S.; Sadykov, K.S.; Khodzhniiazov, F.B. 1992: Organization of prophylactic mass screening for tuberculosis of the population in the south of the Aral sea cost region Problemy Tuberkuleza 1992(3-4): 4-6
Kazimierczak, J.; Górnicka-Wilczyńska, M.; Hanke, W.; Wagrowska-Koski, E. 2007: The incidence of tuberculosis in Poland and other E.U. countries and the Russian Federation, Belarus and Ukraine: implications for prophylactic activities Medycyna Pracy 58(4): 353-360
Loginov, A.S.; Matiushin, B.N. 1994: Intracellular oxygen activation and molecular mechanisms of oxidative hepatic damage Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 5: 3-7
Galmarini, D.; Tarenzi, L.; Cantaluppi, G.; Fassati, L.R.; Mauri, A.; Zanandrea, G.; Fabiani, M.P.; Doglia, M.; Radice, F.; Viale, G.; Trabucchi, E. 1978: Acute hepatic failure and renal damage. Experimental and clinical studies Minerva Medica 69(21): 1417-1426